Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Glucagon in Type 1 and Type 2 Diabetes
NCT02806960Phase 1Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2014
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of glucagon in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Jun 2014; status: terminated.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02806960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806960.